发明名称 Anti-cancer gene therapy by modulation of immune or inflammatory response
摘要 Use of a viral vector contg. in its genome a DNA fragment (I) contg. ≥ 1 gene encoding all or part of an agent (A) that modulates the immune and/or inflammatory response for the treatment of cancer in mammals is new. (A) can be a cell surface co-stimulatory molecule, a chemokine, a monoclonal antibody against a lymphocyte surface maker, a super antigen characteristic of an infectious organism (bacterium, virus or parasite), a polypeptide with adjuvant activity or esp. a cytokine. Also claimed is the use of a viral vector with positive tropism for cancer cells contg. in its genome a DNA fragment including ≥ 1 gene, encoding an agent able to destroy cancer cells, under control of appropriate expression elements, for selective delivery of the agent to cancerous tumours.
申请公布号 HK1042728(A1) 申请公布日期 2006.11.24
申请号 HK20020103801 申请日期 2002.05.21
申请人 TRANSGENE S.A. 发明人 BRUCE ACRES
分类号 C12N;C12N15/09;A61K;A61K35/76;A61K38/00;A61K38/19;A61K38/20;A61K38/21;A61K39/00;A61K39/39;A61K39/395;A61K48/00;A61P35/00;C07K;C07K14/535;C07K14/54;C07K14/56;C12N15/13;C12N15/24;C12N15/26;C12N15/863;C12P21/02 主分类号 C12N
代理机构 代理人
主权项
地址